If you enjoy this content, please share it with a colleague
RELATED CONTENT
March 30, 2009 – Lantheus Medical Imaging Inc. released at ACC 2009 new data regarding the use of DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension that finds significant survival benefit for critically ill patients undergoing contrast-enhanced echocardiography.
March 25, 2009 – Lantheus Medical Imaging Inc.
February 24, 2009 - Lantheus Medical Imaging Inc. today said a paper published online in the February 2009 issue of the Journal of the American College of Cardiology reinforces the clinical use and impact of its echocardiography contrast agent DEFINITY Vial For (Perflutren Lipid Microsphere) Injectable Suspension in hospitalized and critically ill cardiac patients.
January 27, 2009 - Lantheus Medical Imaging Inc. said today new data from a prospective, non-randomized, multi-national ...
December 15, 2008 - Lantheus Medical Imaging reported that new data from a retrospective, multicenter, cohort study of over four million hospitalized patients showed similar unadjusted mortality rates for patients receiving DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension enhanced resting echocardiography exams when compared with patients who did not receive DEFINITY.
November 6, 2008 - Lantheus Medical Imaging Inc. welcomes the “Consensus Statement on the Clinical Applications of Ultrasound Contrast” released by the American Society of Echocardiography (ASE) published in the November issue of the Journal of the American Society of Echocardiography.
October 23, 2008 - Premier Purchasing Partners signed a new agreement for cardiac ultrasound contrast media with Lantheus Medical Imaging of North Billerica, MA.
September 23, 2008 – In response to the FDA approval of Covidien’s ANDA for generic Kit for the Preparation of ...
September 24, 2008 - Bracco Diagnostics Inc. and Lantheus Medical Imaging Inc. said yesterday they entered into an ...
September 9, 2008 - Lantheus Medical Imaging Inc. issued a statement assuring regulatory authorities, key customers and ...